truximahcp.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
User-agent: * Allow: / Disallow: /search-results Sitemap: | ||
Meta Tags
| Title | Home - TRUXIMA® (rituximab-abbs) HCP |
| Description | Biosimilar by Learn about clinical evidence for TRUXIMA®, dosage and administration, cost, and support service |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 45.60.171.76 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
truximahcp.com Valuation
|
US$5,141,796
Last updated: 2023-05-03 15:51:22
truximahcp.com has Semrush global rank of 2,058,484. truximahcp.com has an estimated worth of US$ 5,141,796, based on its estimated Ads revenue. truximahcp.com receives approximately 593,285 unique visitors each day. Its web server is located in United States, with IP address 45.60.171.76. According to SiteAdvisor, truximahcp.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$5,141,796 |
| Daily Ads Revenue | US$4,747 |
| Monthly Ads Revenue | US$142,389 |
| Yearly Ads Revenue | US$1,708,659 |
| Daily Unique Visitors | 39,553 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| truximahcp.com. | A | 7199 | IP: 45.60.171.76 |
| truximahcp.com. | A | 7199 | IP: 45.60.151.76 |
| truximahcp.com. | NS | 86400 | NS Record: ns4.tevapharm.com. |
| truximahcp.com. | NS | 86400 | NS Record: ns5.tevapharm.com. |
| truximahcp.com. | NS | 86400 | NS Record: ns3.tevapharm.com. |
| truximahcp.com. | TXT | 86400 | TXT Record: _globalsign-domain-verification=vaTsmdSHadjMAOQTeuefgxu48xjFAJM2wezB4f0roD |
| truximahcp.com. | TXT | 86400 | TXT Record: v=spf1 -all |
HtmlToTextCheckTime:2023-05-03 15:51:22
| Important Safety Information Prescribing Information Patient Site Home About TRUXIMA Clinical Evidence Supply & Dosage About Biosimilars Support & Resources Search form Search form Close Home About TRUXIMA Clinical Evidence Supply & Dosage About Biosimilars Support & Resources Biosimilar by Design The First FDA-approved Biosimilar Rituximab - Initial approval in the US, November 2018 1 TRUXIMA is highly similar to Rituxan ® (rituximab) for the indications listed below, with no clinically meaningful differences in terms of safety, purity, and potency. 2-4 Our key priority is offering competitive pricing for TRUXIMA. Teva offers dedicated patient support services. Get to know TRUXIMA . Biosimilars Are Rigorously Evaluated The biosimilarity of TRUXIMA is demonstrated by a totality of evidence 2,4,5 View clinical evidence Dedicated Support Teva offers reimbursement access and patient support programs Explore support & resources Toggle INDICATIONS TRUXIMA is indicated for the treatment of |
HTTP Headers
HTTP/1.1 301 Moved Permanently Location: https://www.truximahcp.com/ Content-Length: 0 Connection: close HTTP/2 200 cache-control: no-cache pragma: no-cache content-length: 31815 content-type: text/html; charset=utf-8 expires: -1 server: Microsoft-IIS/10.0 set-cookie: ASP.NET_SessionId=fpr2yxcw5e54ichcmwtwyrjm; path=/; HttpOnly; SameSite=Lax x-aspnetmvc-version: 5.2 x-aspnet-version: 4.0.30319 x-powered-by: ASP.NET arr-disable-session-affinity: true x-frame-options: DENY date: Mon, 25 Oct 2021 21:18:19 GMT set-cookie: visid_incap_2160413=IxBnDrLVQ9OybiUzF1JXLRsfd2EAAAAAQUIPAAAAAABr4ZdUURHdx+H9bcmbu3mb; expires=Tue, 25 Oct 2022 11:20:48 GMT; HttpOnly; path=/; Domain=.truximahcp.com set-cookie: nlbi_2160413=JNW1Sdw8UGAiNjmMS6TJtAAAAABMtaRJJcexBBh7dxng7GW+; path=/; Domain=.truximahcp.com set-cookie: incap_ses_8222_2160413=LTpWDqIQsTeIWwNplWkachsfd2EAAAAAJClxuLmFLWgt0NYB6jX6ew==; path=/; Domain=.truximahcp.com x-cdn: Imperva x-iinfo: 14-124511542-124511544 NNNN CT(25 51 0) RT(1635196699476 0) q(0 0 1 5) r(2 2) U6 |
truximahcp.com Whois Information
Domain Name: TRUXIMAHCP.COM Registry Domain ID: 2208922048_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.comlaude.com Registrar URL: http://www.comlaude.com Updated Date: 2020-12-30T23:06:27Z Creation Date: 2018-01-04T22:29:49Z Registry Expiry Date: 2022-01-04T22:29:49Z Registrar: Nom-iq Ltd. dba COM LAUDE Registrar IANA ID: 470 Registrar Abuse Contact Email: abuse@comlaude.com Registrar Abuse Contact Phone: +442074218250 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS3.TEVAPHARM.COM Name Server: NS4.TEVAPHARM.COM Name Server: NS5.TEVAPHARM.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-13T23:20:53Z <<< |